Pharmacy News

CDC recommends new drug to protect infants from RSV

In July, FDA approved nirsevimab-alip (Beyfortus—Sanofi/AstraZeneca). A few weeks later, on August 3, 2023, CDC’s ACIP voted unanimously to recommend the broad use of the new drug to infants and high-risk children for protection against respiratory syncytial virus (RSV).

FDA issues first guidance for clinical trials with psychedelics

FDA has issued new draft guidance geared toward industry regarding considerations for designing clinical trials involving psychedelic drugs.

Daily statin reduces heart disease risk among adults living with HIV

A new study published in NEJM found that cholesterol-lowering statin drugs helped curb the risk of significant CVD in people living with HIV by more than one-third, potentially preventing one in five major CV events or premature deaths in this population.

AHA: Vaping harms heart and lungs

In a new scientific statement, the American Heart Association (AHA) is urging more research about the detrimental effects of vaping on the heart and lungs.

WHO says global childhood vaccinations closer to prepandemic levels

Childhood vaccinations worldwide are rising to coverage levels close to those seen before the COVID-19 pandemic, according to new data from WHO and UNICEF.